Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin
利用FDA批准的利托那韦和二甲双胍靶向多发性骨髓瘤的代谢可塑性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-14-1088
Dalva-Aydemir, Sevim; Bajpai, Richa; Martinez, Maylyn; Adekola, Kehinde U A; Kandela, Irawati; Wei, Changyong; Singhal, Seema; Koblinski, Jennifer E; Raje, Noopur S; Rosen, Steven T; Shanmugam, Mala
